337 related articles for article (PubMed ID: 20540111)
1. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
[TBL] [Abstract][Full Text] [Related]
3. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
4. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
[TBL] [Abstract][Full Text] [Related]
5. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
7. T cell vaccination against autoimmune diabetes in nonobese diabetic mice.
Formby B; Shao T
Ann Clin Lab Sci; 1993; 23(2):137-47. PubMed ID: 8096128
[TBL] [Abstract][Full Text] [Related]
8. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
9. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera.
Casares S; Hurtado A; McEvoy RC; Sarukhan A; von Boehmer H; Brumeanu TD
Nat Immunol; 2002 Apr; 3(4):383-91. PubMed ID: 11862219
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
Li L; Yi Z; Wang B; Tisch R
J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
[TBL] [Abstract][Full Text] [Related]
12. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
13. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
14. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
15. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
17. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
18. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
19. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]